Family facts
IDVParent PIID75N91019D00024
AgencyNih Nci
Awarding officeNih Nci
Awarding agencyDepartment of Health and Human Services (HHS)
Period endSep 28, 2031
IDV obligated$1.9B
Child awards86
Want the durability read on 75N91019D00024? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Places of performance
StatesMD
Distinctive task orders
1275N91020F00003 — NCI OPERATIONAL TASK ORDER.
Leidos Biomedical Research, Inc. · $1.8B · PoP Jun 20, 2025
75N91020F00039 — NIAID COVID-19 ACTIV3
Leidos Biomedical Research, Inc. · $281.6M · PoP Sep 29, 2029
75N91019F00139 — MD NET
Leidos Biomedical Research, Inc. · $181.4M · PoP Oct 31, 2029
75N91021F00004 — ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)
Leidos Biomedical Research, Inc. · $141.7M · PoP Jan 28, 2031
75N91019F00133 — FFRDC TASK ORDER - LEASES
Leidos Biomedical Research, Inc. · $127.1M · PoP Jan 31, 2025
75N91020F00006 — NIAID VRC OPERATIONAL TASK ORDER; COVID: VRC IS ENGAGED IN EVALUATING MRNA VACCINES FOR DIFFERENT VARIANTS IN ANIMAL MO…
Leidos Biomedical Research, Inc. · $125.8M · PoP Nov 29, 2024
75N91021F00013 — ENABLING NCI CLINICAL & RESEARCH DATA SHARING
Leidos Biomedical Research, Inc. · $98.6M · PoP Feb 28, 2028
75N91020F00025 — DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEO…
Leidos Biomedical Research, Inc. · $97.5M · PoP Sep 24, 2028
75N91020F00009 — ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED…
Leidos Biomedical Research, Inc. · $89.6M · PoP Jul 31, 2028
75N91020F00010 — INITIATE THE MANAGEMENT, OVERSIGHT, AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED "A MULTICENTER, ADAPTIVE, RANDO…
Leidos Biomedical Research, Inc. · $83.4M · PoP Apr 2, 2025
75N91026F00034 — FUNCTIONAL PRECISION MEDICINE AND RESPONSE ASSAYS
Leidos Biomedical Research, Inc. · $72.2M · PoP Sep 28, 2031
75N91020F00011 — NIAID DMID BIG EFFECT TRIAL (BET) - INITIATE THE MANAGEMENT, OVERSIGHT, AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL…
Leidos Biomedical Research, Inc. · $62.1M · PoP Nov 29, 2024
Want the durability read on 75N91019D00024? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
Get the free Exposure Check
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
Data as of · refreshed monthly